Stephen J. Kish - Publications

Affiliations: 
University of Toronto, Toronto, ON, Canada 
Area:
Neuroscience Biology

201 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Tong J, Fitzmaurice PS, Moszczynska A, Rathitharan G, Ang LC, Meyer JH, Mizrahi R, Boileau I, Furukawa Y, McCluskey T, Sailasuta N, Kish SJ. Normal glutathione levels in autopsied brain of chronic users of heroin and of cocaine. Drug and Alcohol Dependence. 190: 20-28. PMID 29960919 DOI: 10.1016/j.drugalcdep.2018.05.021  0.64
2017 Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: possible functional implications. The European Journal of Neuroscience. 45: 1356. PMID 28523903 DOI: 10.1111/ejn.13573  0.4
2016 Sitte HH, Pifl C, Rajput AH, Hörtnagl H, Tong J, Lloyd GK, Kish SJ, Hornykiewicz O. Dopamine and noradrenaline, but not serotonin, in the human claustrum are greatly reduced in patients with Parkinson's disease: Possible functional implications. The European Journal of Neuroscience. PMID 27741357 DOI: 10.1111/ejn.13435  0.4
2016 Kish SJ, Boileau I, Callaghan RC, Tong J. Brain dopamine neurone "damage": methamphetamine users vs. parkinson's disease ─ A critical assessment of the evidence. The European Journal of Neuroscience. PMID 27519465 DOI: 10.1111/ejn.13363  0.64
2016 Furukawa Y, Rajput AH, Tong J, Tomizawa Y, Hornykiewicz O, Kish SJ. A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia. Neurology. PMID 27488599 DOI: 10.1212/WNL.0000000000003065  0.64
2016 Boileau I, Payer D, Rusjan PM, Houle S, Tong J, McCluskey T, Wilson AA, Kish SJ. Heightened Dopaminergic Response to Amphetamine at the D3 Dopamine Receptor in Methamphetamine Users. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27353309 DOI: 10.1038/npp.2016.108  0.64
2016 Tong J, Fitzmaurice PS, Moszczynska A, Mattina K, Ang LC, Boileau I, Furukawa Y, Sailasuta N, Kish SJ. Do glutathione levels decline in aging human brain? Free Radical Biology & Medicine. PMID 26845616 DOI: 10.1016/j.freeradbiomed.2016.01.029  0.64
2015 Payer DE, Guttman M, Kish SJ, Tong J, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. D3 dopamine receptor-preferring [11C]PHNO PET imaging in Parkinson patients with dyskinesia. Neurology. PMID 26718579 DOI: 10.1212/WNL.0000000000002285  0.64
2015 Boileau I, McCluskey T, Tong J, Furukawa Y, Houle S, Kish SJ. Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 26321315 DOI: 10.1038/npp.2015.267  0.64
2015 Chiuccariello L, Cooke RG, Miler L, Levitan RD, Baker GB, Kish SJ, Kolla NJ, Rusjan PM, Houle S, Wilson AA, Meyer JH. Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26316187 DOI: 10.1093/ijnp/pyv078  0.64
2015 Zack M, Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh JJ, Kish SJ. Differential cardiovascular and hypothalamic pituitary response to amphetamine in male pathological gamblers versus healthy controls. Journal of Psychopharmacology (Oxford, England). PMID 26152320 DOI: 10.1177/0269881115592338  0.64
2015 Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation. Neurobiology of Disease. 82: 243-253. PMID 26102022 DOI: 10.1016/j.nbd.2015.06.010  0.32
2015 Boileau I, Rusjan PM, Williams B, Mansouri E, Mizrahi R, De Luca V, Johnson DS, Wilson AA, Houle S, Kish SJ, Tong J. Blocking of fatty acid amide hydrolase activity with PF-04457845 in human brain: a positron emission tomography study with the novel radioligand [(11)C]CURB. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26082009 DOI: 10.1038/jcbfm.2015.133  0.64
2015 Boileau I, Tyndale RF, Williams B, Mansouri E, Westwood DJ, Foll BL, Rusjan PM, Mizrahi R, De Luca V, Zhou Q, Wilson AA, Houle S, Kish SJ, Tong J. The fatty acid amide hydrolase C385A variant affects brain binding of the positron emission tomography tracer [(11)C]CURB. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. PMID 26036940 DOI: 10.1038/jcbfm.2015.119  0.64
2015 Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 160-6. PMID 25641350 DOI: 10.1002/mds.26135  0.64
2015 Furukawa Y, Kish SJ. Parkinsonism in GTP cyclohydrolase 1-deficient DOPA-responsive dystonia Brain. 138: e351. PMID 25416181 DOI: 10.1093/brain/awu325  0.64
2015 Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Low levels of astroglial markers in Parkinson's disease: Relationship to α-synuclein accumulation Neurobiology of Disease. 82: 243-253. DOI: 10.1016/j.nbd.2015.06.010  0.64
2014 Boileau I, Bloomfield PM, Rusjan P, Mizrahi R, Mufti A, Vitcu I, Kish SJ, Houle S, Wilson AA, Tong J. Whole-body radiation dosimetry of 11C-carbonyl-URB694: a PET tracer for fatty acid amide hydrolase. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 1993-7. PMID 25413137 DOI: 10.2967/jnumed.114.146464  0.64
2014 Tong J, Fitzmaurice P, Furukawa Y, Schmunk GA, Wickham DJ, Ang LC, Sherwin A, McCluskey T, Boileau I, Kish SJ. Is brain gliosis a characteristic of chronic methamphetamine use in the human? Neurobiology of Disease. 67: 107-18. PMID 24704312 DOI: 10.1016/j.nbd.2014.03.015  0.64
2014 Kitami M, Oizumi H, Kish SJ, Furukawa Y. Takotsubo cardiomyopathy associated with lithium intoxication in bipolar disorder: a case report. Journal of Clinical Psychopharmacology. 34: 410-1. PMID 24699038 DOI: 10.1097/JCP.0b013e3182a95a27  0.64
2014 Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. Molecular Psychiatry. 19: 1305-13. PMID 24322203 DOI: 10.1038/mp.2013.163  0.64
2014 Matthews BA, Kish SJ, Xu X, Boileau I, Rusjan PM, Wilson AA, DiGiacomo D, Houle S, Meyer JH. Greater monoamine oxidase a binding in alcohol dependence. Biological Psychiatry. 75: 756-64. PMID 24269057 DOI: 10.1016/j.biopsych.2013.10.010  0.64
2014 Chiuccariello L, Houle S, Miler L, Cooke RG, Rusjan PM, Rajkowska G, Levitan RD, Kish SJ, Kolla NJ, Ou X, Wilson AA, Meyer JH. Elevated monoamine oxidase a binding during major depressive episodes is associated with greater severity and reversed neurovegetative symptoms. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 973-80. PMID 24154665 DOI: 10.1038/npp.2013.297  0.64
2014 Payer DE, Behzadi A, Kish SJ, Houle S, Wilson AA, Rusjan PM, Tong J, Selby P, George TP, McCluskey T, Boileau I. Heightened D3 dopamine receptor levels in cocaine dependence and contributions to the addiction behavioral phenotype: a positron emission tomography study with [11C]-+-PHNO. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 311-8. PMID 23921256 DOI: 10.1038/npp.2013.192  0.64
2013 Tong J, Meyer JH, Furukawa Y, Boileau I, Chang LJ, Wilson AA, Houle S, Kish SJ. Distribution of monoamine oxidase proteins in human brain: implications for brain imaging studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 863-71. PMID 23403377 DOI: 10.1038/jcbfm.2013.19  0.64
2013 Rusjan PM, Wilson AA, Mizrahi R, Boileau I, Chavez SE, Lobaugh NJ, Kish SJ, Houle S, Tong J. Mapping human brain fatty acid amide hydrolase activity with PET. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 407-14. PMID 23211960 DOI: 10.1038/jcbfm.2012.180  0.64
2013 Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM, Houle S, Wilson AA, Warsh J, Kish SJ, Zack M. The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction (Abingdon, England). 108: 953-63. PMID 23167711 DOI: 10.1111/add.12066  0.64
2013 Kish SJ. The Pathology of Methamphetamine Use in the Human Brain The Effects of Drug Abuse On the Human Nervous System. 203-297. DOI: 10.1016/B978-0-12-418679-8.00008-3  0.64
2012 Pifl C, Kish SJ, Hornykiewicz O. Thalamic noradrenaline in Parkinson's disease: deficits suggest role in motor and non-motor symptoms. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1618-24. PMID 23038412 DOI: 10.1002/mds.25109  0.64
2012 Callaghan RC, Cunningham JK, Verdichevski M, Sykes J, Jaffer SR, Kish SJ. All-cause mortality among individuals with disorders related to the use of methamphetamine: a comparative cohort study. Drug and Alcohol Dependence. 125: 290-4. PMID 22503689 DOI: 10.1016/j.drugalcdep.2012.03.004  0.64
2012 Boileau I, Payer D, Houle S, Behzadi A, Rusjan PM, Tong J, Wilkins D, Selby P, George TP, Zack M, Furukawa Y, McCluskey T, Wilson AA, Kish SJ. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 1353-9. PMID 22279219 DOI: 10.1523/JNEUROSCI.4371-11.2012  0.64
2012 Callaghan RC, Cunningham JK, Allebeck P, Arenovich T, Sajeev G, Remington G, Boileau I, Kish SJ. Methamphetamine use and schizophrenia: a population-based cohort study in California. The American Journal of Psychiatry. 169: 389-96. PMID 22193527 DOI: 10.1176/appi.ajp.2011.10070937  0.64
2012 Sacher J, Rabiner EA, Clark M, Rusjan P, Soliman A, Boskovic R, Kish SJ, Wilson AA, Houle S, Meyer JH. Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [(11)C]-harmine positron emission tomography study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 32: 443-6. PMID 22186668 DOI: 10.1038/jcbfm.2011.184  0.64
2012 Mann A, Miksys SL, Gaedigk A, Kish SJ, Mash DC, Tyndale RF. The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients. Neurobiology of Aging. 33: 2160-71. PMID 21958961 DOI: 10.1016/j.neurobiolaging.2011.08.014  0.64
2012 Callaghan RC, Cunningham JK, Sykes J, Kish SJ. Increased risk of Parkinson's disease in individuals hospitalized with conditions related to the use of methamphetamine or other amphetamine-type drugs. Drug and Alcohol Dependence. 120: 35-40. PMID 21794992 DOI: 10.1016/j.drugalcdep.2011.06.013  0.64
2011 Bacher I, Houle S, Xu X, Zawertailo L, Soliman A, Wilson AA, Selby P, George TP, Sacher J, Miler L, Kish SJ, Rusjan P, Meyer JH. Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. Archives of General Psychiatry. 68: 817-26. PMID 21810646 DOI: 10.1001/archgenpsychiatry.2011.82  0.64
2011 Tong J, Boileau I, Furukawa Y, Chang LJ, Wilson AA, Houle S, Kish SJ. Distribution of vesicular monoamine transporter 2 protein in human brain: implications for brain imaging studies. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 31: 2065-75. PMID 21522164 DOI: 10.1038/jcbfm.2011.63  0.64
2011 Tong J, Furukawa Y, Sherwin A, Hornykiewicz O, Kish SJ. Heterogeneous intrastriatal pattern of proteins regulating axon growth in normal adult human brain. Neurobiology of Disease. 41: 458-68. PMID 21029775 DOI: 10.1016/j.nbd.2010.10.017  0.64
2010 Callaghan RC, Cunningham JK, Sajeev G, Kish SJ. Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2333-9. PMID 20737543 DOI: 10.1002/mds.23263  0.64
2010 Kish SJ, Lerch J, Furukawa Y, Tong J, McCluskey T, Wilkins D, Houle S, Meyer J, Mundo E, Wilson AA, Rusjan PM, Saint-Cyr JA, Guttman M, Collins DL, Shapiro C, et al. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study. Brain : a Journal of Neurology. 133: 1779-97. PMID 20483717 DOI: 10.1093/brain/awq103  0.64
2010 Boileau I, Houle S, Rusjan PM, Furukawa Y, Wilkins D, Tong J, Selby P, Wilson AA, Kish SJ. Influence of a low dose of amphetamine on vesicular monoamine transporter binding: a PET (+)[11C]DTBZ study in humans. Synapse (New York, N.Y.). 64: 417-20. PMID 20169578 DOI: 10.1002/syn.20743  0.64
2010 Tong J, Wong H, Guttman M, Ang LC, Forno LS, Shimadzu M, Rajput AH, Muenter MD, Kish SJ, Hornykiewicz O, Furukawa Y. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation. Brain : a Journal of Neurology. 133: 172-88. PMID 19903734 DOI: 10.1093/brain/awp282  0.64
2010 Kish SJ, Fitzmaurice PS, Chang LJ, Furukawa Y, Tong J. Low striatal serotonin transporter protein in a human polydrug MDMA (ecstasy) user: a case study. Journal of Psychopharmacology (Oxford, England). 24: 281-4. PMID 18832433 DOI: 10.1177/0269881108097724  0.64
2009 Roedding AS, Gao AF, Wu AM, Li PP, Kish SJ, Warsh JJ. TRPC3 protein is expressed across the lifespan in human prefrontal cortex and cerebellum. Brain Research. 1260: 1-6. PMID 19168035 DOI: 10.1016/j.brainres.2008.12.069  0.64
2009 Boileau I, Guttman M, Rusjan P, Adams JR, Houle S, Tong J, Hornykiewicz O, Furukawa Y, Wilson AA, Kapur S, Kish SJ. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease. Brain : a Journal of Neurology. 132: 1366-75. PMID 19153147 DOI: 10.1093/brain/awn337  0.64
2009 Kish SJ, Fitzmaurice PS, Boileau I, Schmunk GA, Ang LC, Furukawa Y, Chang LJ, Wickham DJ, Sherwin A, Tong J. Brain serotonin transporter in human methamphetamine users. Psychopharmacology. 202: 649-61. PMID 18841348 DOI: 10.1007/s00213-008-1346-x  0.64
2008 Boileau I, Rusjan P, Houle S, Wilkins D, Tong J, Selby P, Guttman M, Saint-Cyr JA, Wilson AA, Kish SJ. Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker? The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 9850-6. PMID 18815269 DOI: 10.1523/JNEUROSCI.3008-08.2008  0.64
2008 Tong J, Wilson AA, Boileau I, Houle S, Kish SJ. Dopamine modulating drugs influence striatal (+)-[11C]DTBZ binding in rats: VMAT2 binding is sensitive to changes in vesicular dopamine concentration. Synapse (New York, N.Y.). 62: 873-6. PMID 18720517 DOI: 10.1002/syn.20573  0.64
2008 Boileau I, Warsh JJ, Guttman M, Saint-Cyr JA, McCluskey T, Rusjan P, Houle S, Wilson AA, Meyer JH, Kish SJ. Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASB. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1776-80. PMID 18661545 DOI: 10.1002/mds.22212  0.64
2008 Kish SJ. Pharmacologic mechanisms of crystal meth. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 178: 1679-82. PMID 18559805 DOI: 10.1503/cmaj.071675  0.64
2008 Frankel PS, Alburges ME, Bush L, Hanson GR, Kish SJ. Striatal and ventral pallidum dynorphin concentrations are markedly increased in human chronic cocaine users. Neuropharmacology. 55: 41-6. PMID 18538358 DOI: 10.1016/j.neuropharm.2008.04.019  0.64
2008 Kish SJ, Tong J, Hornykiewicz O, Rajput A, Chang LJ, Guttman M, Furukawa Y. Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease. Brain : a Journal of Neurology. 131: 120-31. PMID 17956909 DOI: 10.1093/brain/awm239  0.64
2007 Frankel PS, Alburges ME, Bush L, Hanson GR, Kish SJ. Brain levels of neuropeptides in human chronic methamphetamine users. Neuropharmacology. 53: 447-54. PMID 17688891 DOI: 10.1016/j.neuropharm.2007.06.009  0.64
2007 Martin TL, Chiasson DA, Kish SJ. Does hyperthyroidism increase risk of death due to the ingestion of ecstasy? Journal of Forensic Sciences. 52: 951-3. PMID 17524054 DOI: 10.1111/j.1556-4029.2007.00463.x  0.64
2007 Tong J, Hornykiewicz O, Furukawa Y, Kish SJ. Marked dissociation between high noradrenaline versus low noradrenaline transporter levels in human nucleus accumbens. Journal of Neurochemistry. 102: 1691-702. PMID 17484728 DOI: 10.1111/j.1471-4159.2007.04636.x  0.64
2007 Guttman M, Boileau I, Warsh J, Saint-Cyr JA, Ginovart N, McCluskey T, Houle S, Wilson A, Mundo E, Rusjan P, Meyer J, Kish SJ. Brain serotonin transporter binding in non-depressed patients with Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 14: 523-8. PMID 17437611 DOI: 10.1111/j.1468-1331.2007.01727.x  0.64
2006 Tong J, Hornykiewicz O, Kish SJ. Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline. Archives of Neurology. 63: 1724-8. PMID 17172611 DOI: 10.1001/archneur.63.12.1724  0.64
2006 Fitzmaurice PS, Tong J, Yazdanpanah M, Liu PP, Kalasinsky KS, Kish SJ. Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine. The Journal of Pharmacology and Experimental Therapeutics. 319: 703-9. PMID 16857724 DOI: 10.1124/jpet.106.109173  0.64
2006 Ross BM, Hughes B, Kish SJ, Warsh JJ. Serum calcium-independent phospholipase A2 activity in bipolar affective disorder. Bipolar Disorders. 8: 265-70. PMID 16696828 DOI: 10.1111/j.1399-5618.2006.00299.x  0.64
2006 Tong J, Hornykiewicz O, Kish SJ. Identification of a noradrenaline-rich subdivision of the human nucleus accumbens. Journal of Neurochemistry. 96: 349-54. PMID 16336226 DOI: 10.1111/j.1471-4159.2005.03546.x  0.64
2005 Kish SJ, Furukawa Y, Chang LJ, Tong J, Ginovart N, Wilson A, Houle S, Meyer JH. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region? Nuclear Medicine and Biology. 32: 123-8. PMID 15721757 DOI: 10.1016/j.nucmedbio.2004.10.001  0.64
2005 Ravina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, ... Kish SJ, et al. The role of radiotracer imaging in Parkinson disease. Neurology. 64: 208-15. PMID 15668415 DOI: 10.1212/01.WNL.0000149403.14458.7F  0.64
2004 Kalasinsky KS, Hugel J, Kish SJ. Use of MDA (the "love drug") and methamphetamine in Toronto by unsuspecting users of ecstasy (MDMA). Journal of Forensic Sciences. 49: 1106-12. PMID 15461119  0.64
2004 Furukawa Y, Filiano JJ, Kish SJ. Amantadine for levodopa-induced choreic dyskinesia in compound heterozygotes for GCH1 mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 19: 1256-8. PMID 15389992 DOI: 10.1002/mds.20194  0.64
2004 Mirecki A, Fitzmaurice P, Ang L, Kalasinsky KS, Peretti FJ, Aiken SS, Wickham DJ, Sherwin A, Nobrega JN, Forman HJ, Kish SJ. Brain antioxidant systems in human methamphetamine users. Journal of Neurochemistry. 89: 1396-408. PMID 15189342 DOI: 10.1111/j.1471-4159.2004.02434.x  0.64
2004 Siegal D, Erickson J, Varoqui H, Ang L, Kalasinsky KS, Peretti FJ, Aiken SS, Wickham DJ, Kish SJ. Brain vesicular acetylcholine transporter in human users of drugs of abuse. Synapse (New York, N.Y.). 52: 223-32. PMID 15103689 DOI: 10.1002/syn.20020  0.64
2004 Furukawa Y, Kish SJ, Fahn S. Dopa-responsive dystonia due to mild tyrosine hydroxylase deficiency. Annals of Neurology. 55: 147-8. PMID 14705130 DOI: 10.1002/ana.10820  0.64
2004 Tong J, Fitzmaurice PS, Ang LC, Furukawa Y, Guttman M, Kish SJ. Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Annals of Neurology. 55: 125-9. PMID 14705122 DOI: 10.1002/ana.10814  0.64
2004 Moszczynska A, Fitzmaurice P, Ang L, Kalasinsky KS, Schmunk GA, Peretti FJ, Aiken SS, Wickham DJ, Kish SJ. Why is parkinsonism not a feature of human methamphetamine users? Brain : a Journal of Neurology. 127: 363-70. PMID 14645148 DOI: 10.1093/brain/awh046  0.64
2003 Kish SJ. What is the evidence that Ecstasy (MDMA) can cause Parkinson's disease? Movement Disorders : Official Journal of the Movement Disorder Society. 18: 1219-23. PMID 14639660 DOI: 10.1002/mds.10643  0.64
2003 Haycock JW, Becker L, Ang L, Furukawa Y, Hornykiewicz O, Kish SJ. Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum. Journal of Neurochemistry. 87: 574-85. PMID 14535941 DOI: 10.1046/j.1471-4159.2003.02017.x  0.64
2003 Fitzmaurice PS, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 18: 969-76. PMID 14502663 DOI: 10.1002/mds.10486  0.64
2003 Furukawa Y, Guttman M, Wong H, Farrell SA, Furtado S, Kish SJ. Serum prolactin in symptomatic and asymptomatic dopa-responsive dystonia due to a GCH1 mutation. Neurology. 61: 269-70. PMID 12874420  0.64
2003 Andreopoulos S, Li PP, Siu KP, Kish SJ, Warsh JJ. Altered CTX-catalyzed and endogenous [32P]ADP-ribosylation of stimulatory G protein alphas isoforms in postmortem bipolar affective disorder temporal cortex. Journal of Neuroscience Research. 72: 638-45. PMID 12749029 DOI: 10.1002/jnr.10620  0.64
2003 Tong J, Ross BM, Schmunk GA, Peretti FJ, Kalasinsky KS, Furukawa Y, Ang LC, Aiken SS, Wickham DJ, Kish SJ. Decreased striatal dopamine D1 receptor-stimulated adenylyl cyclase activity in human methamphetamine users. The American Journal of Psychiatry. 160: 896-903. PMID 12727693 DOI: 10.1176/appi.ajp.160.5.896  0.64
2003 Guttman M, Kish SJ, Furukawa Y. Current concepts in the diagnosis and management of Parkinson's disease. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 168: 293-301. PMID 12566335  0.64
2003 Vigouroux S, Furukawa Y, Farout L, J Kish S, Briand M, Briand Y. Peptidase activities of the 20/26S proteasome and a novel protease in human brain. Journal of Neurochemistry. 84: 392-6. PMID 12559001 DOI: 10.1046/j.1471-4159.2003.01534.x  0.64
2003 Kish SJ. Biochemistry of Parkinson's disease: is a brain serotonergic deficiency a characteristic of idiopathic Parkinson's disease? Advances in Neurology. 91: 39-49. PMID 12442662  0.64
2002 Swerdlow RH, Kish SJ. Mitochondria in Alzheimer's disease. International Review of Neurobiology. 53: 341-85. PMID 12512346  0.64
2002 Furukawa Y, Kapatos G, Haycock JW, Worsley J, Wong H, Kish SJ, Nygaard TG. Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia. Annals of Neurology. 51: 637-41. PMID 12112113 DOI: 10.1002/ana.10175  0.64
2002 Furukawa Y, Vigouroux S, Wong H, Guttman M, Rajput AH, Ang L, Briand M, Kish SJ, Briand Y. Brain proteasomal function in sporadic Parkinson's disease and related disorders. Annals of Neurology. 51: 779-82. PMID 12112087 DOI: 10.1002/ana.10207  0.64
2002 Fitzmaurice PS, Bamsey CL, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Brain aconitase activity is not decreased in progressive supranuclear palsy Neurology. 59: 137-138. PMID 12105325  0.64
2002 Ross BM, Moszczynska A, Peretti FJ, Adams V, Schmunk GA, Kalasinsky KS, Ang L, Mamalias N, Turenne SD, Kish SJ. Decreased activity of brain phospholipid metabolic enzymes in human users of cocaine and methamphetamine. Drug and Alcohol Dependence. 67: 73-9. PMID 12062780 DOI: 10.1016/S0376-8716(02)00022-4  0.64
2002 Kish SJ. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacology, Biochemistry, and Behavior. 71: 845-55. PMID 11888575 DOI: 10.1016/S0091-3057(01)00708-0  0.64
2001 Tong J, Ross BM, Sherwin AL, Kish SJ. Dopamine D1-stimulated adenylyl cyclase activity in cerebral cortex of autopsied human brain. Neurochemistry International. 39: 117-25. PMID 11408090 DOI: 10.1016/S0197-0186(01)00016-X  0.64
2001 Kish SJ, Kalasinsky KS, Schmunk G, Furukawa Y, Guttman M, Ang L. Dopaminergic changes in human brain following acute exposure to γ-hydroxybutyrate Neurology. 56: 1602-1603. PMID 11402130  0.64
2001 Kalasinsky KS, Dixon MM, Schmunk GA, Kish SJ. Blood, brain, and hair GHB concentrations following fatal ingestion Journal of Forensic Sciences. 46: 728-730. PMID 11373018  0.64
2001 Kish SJ, Kalasinsky KS, Derkach P, Schmunk GA, Guttman M, Ang L, Adams V, Furukawa Y, Haycock JW. Striatal dopaminergic and serotonergic markers in human heroin users Neuropsychopharmacology. 24: 561-567. PMID 11282256 DOI: 10.1016/S0893-133X(00)00209-8  0.64
2001 Kalasinsky KS, Bosy TZ, Schmunk GA, Reiber G, Anthony RM, Furukawa Y, Guttman M, Kish SJ. Regional distribution of methamphetamine in autopsied brain of chronic human methamphetamine users Forensic Science International. 116: 163-169. PMID 11182268 DOI: 10.1016/S0379-0738(00)00368-6  0.64
2001 Ross BM, Mamalias N, Moszczynska A, Rajput AH, Kish SJ. Elevated activity of phospholipid biosynthetic enzymes in substantia nigra of patients with Parkinson's disease. Neuroscience. 102: 899-904. PMID 11182251 DOI: 10.1016/S0306-4522(00)00501-7  0.64
2001 Furukawa Y, Graf WD, Wong H, Shimadzu M, Kish SJ. Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Neurology. 56: 260-3. PMID 11160968  0.64
2000 Worsley JN, Moszczynska A, Falardeau P, Kalasinsky KS, Schmunk G, Guttman M, Furukawa Y, Ang L, Adams V, Reiber G, Anthony RA, Wickham D, Kish SJ. Dopamine D1 receptor protein is elevated in nucleus accumbens of human, chronic methamphetamine users. Molecular Psychiatry. 5: 664-72. PMID 11126397  0.64
2000 Kalasinsky KS, Bosy TZ, Schmunk GA, Ang L, Adams VI, Gore SB, Smialek J, Furukawa Y, Guttman M, Kish SJ. Regional distribution of cocaine in postmortem brain of chronic human cocaine users Journal of Forensic Sciences. 45: 1041-1048. PMID 11005179  0.64
2000 Kish SJ, Furukawa Y, Ang L, Vorce SP, Kalasinsky KS. Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user Neurology. 55: 294-296. PMID 10908909  0.64
2000 Furukawa Y, Kish SJ, Lang AE. Scoliosis in a dopa-responsive dystonia family with a mutation of the GTP cyclohydrolase I gene Neurology. 54: 2187. PMID 10851395  0.64
2000 McLeman ER, Warsh JJ, Ang L, Li PP, Kalasinsky KS, Ross BM, Tong J, Schmunk G, Adams V, Kish SJ. The human nucleus accumbens is highly susceptible to G protein down-regulation by methamphetamine and heroin. Journal of Neurochemistry. 74: 2120-6. PMID 10800957 DOI: 10.1046/j.1471-4159.2000.0742120.x  0.64
2000 Furukawa Y, Guttman M, Sparagana SP, Trugman JM, Hyland K, Wyatt P, Lang AE, Rouleau GA, Shimadzu M, Kish SJ. Dopa-responsive dystonia due to a large deletion in the GTP cyclohydrolase I gene Annals of Neurology. 47: 517-520. PMID 10762165 DOI: 10.1002/1531-8249(200004)47:4<517::AID-ANA17>3.0.CO;2-B  0.64
2000 Ross BM, Eder K, Moszczynska A, Mamalias N, Lamarche J, Ang L, Pandolfo M, Rouleau G, Kirchgessner M, Kish SJ. Abnormal activity of membrane phospholipid synthetic enzymes in the brain of patients with Friedreich's ataxia and spinocerebellar atrophy type-1. Movement Disorders : Official Journal of the Movement Disorder Society. 15: 294-300. PMID 10752579 DOI: 10.1002/1531-8257(200003)15:2<294::AID-MDS1013>3.0.CO;2-D  0.64
2000 Furukawa Y, Hornykiewicz O, Fahn S, Kish SJ. Striatal dopamine in early-onset primary torsion dystonia with the DYT1 mutation. Neurology. 54: 1193-5. PMID 10720299  0.64
1999 Reiach JS, Li PP, Warsh JJ, Kish SJ, Young LT. Reduced adenylyl cyclase immunolabeling and activity in postmortem temporal cortex of depressed suicide victims Journal of Affective Disorders. 56: 141-151. PMID 10701471 DOI: 10.1016/S0165-0327(99)00048-8  0.64
1999 Fields A, Li PP, Kish SJ, Warsh JJ. Increased cyclic AMP-dependent protein kinase activity in postmortem brain from patients with bipolar affective disorder Journal of Neurochemistry. 73: 1704-1710. PMID 10501218 DOI: 10.1046/j.1471-4159.1999.731704.x  0.64
1999 Furukawa Y, Nygaard TG, Gütlich M, Rajput AH, Pifl C, DiStefano L, Chang LJ, Price K, Shimadzu M, Hornykiewicz O, Haycock JW, Kish SJ. Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia. Neurology. 53: 1032-41. PMID 10496263  0.64
1999 Furukawa Y, Kish SJ. Dopa-responsive dystonia: Recent advances and remaining issues to be addressed Movement Disorders. 14: 709-715. PMID 10495030 DOI: 10.1002/1531-8257(199909)14:5<709::AID-MDS1001>3.0.CO;2-T  0.64
1999 Fallbrook A, Turenne SD, Mamalias N, Kish SJ, Ross BM. Phosphatidylcholine and phosphatidylethanolamine metabolites may regulate brain phospholipid catabolism via inhibition of lysophospholipase activity. Brain Research. 834: 207-10. PMID 10407117 DOI: 10.1016/S0006-8993(99)01570-X  0.64
1999 Kish SJ, Kalasinsky KS, Furukawa Y, Guttman M, Lang A, Li L, Adams V, Reiber G, Anthony RA, Anderson W, Smialek J, DiStefano L. Brain choline acetyltransferase activity in chronic, human users of cocaine, methamphetamine, and heroin Molecular Psychiatry. 4: 26-32. PMID 10089005  0.64
1999 Ross BM, Turenne S, Moszczynska A, Warsh JJ, Kish SJ. Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia. Brain Research. 821: 407-13. PMID 10064828 DOI: 10.1016/S0006-8993(99)01123-3  0.64
1999 Kish SJ, Mastrogiacomo F, Guttman M, Furukawa Y, Taanman JW, Dozić S, Pandolfo M, Lamarche J, DiStefano L, Chang LJ. Decreased brain protein levels of cytochrome oxidase subunits in Alzheimer's disease and in hereditary spinocerebellar ataxia disorders: a nonspecific change? Journal of Neurochemistry. 72: 700-7. PMID 9930743 DOI: 10.1046/j.1471-4159.1999.0720700.x  0.64
1998 Moszczynska A, Turenne S, Kish SJ. Rat striatal levels of the antioxidant glutathione are decreased following binge administration of methamphetamine. Neuroscience Letters. 255: 49-52. PMID 9839724 DOI: 10.1016/S0304-3940(98)00711-3  0.64
1998 Kish SJ, Lopes-Cendes I, Guttman M, Furukawa Y, Pandolfo M, Rouleau GA, Ross BM, Nance M, Schut L, Ang L, DiStefano L. Brain glyceraldehyde-3-phosphate dehydrogenase activity in human trinucleotide repeat disorders. Archives of Neurology. 55: 1299-304. PMID 9779656 DOI: 10.1001/archneur.55.10.1299  0.64
1998 Eder K, Kish SJ, Kirchgessner M, Ross BM. Brain phospholipids and fatty acids in Friedreich's ataxia and spinocerebellar atrophy type-1. Movement Disorders : Official Journal of the Movement Disorder Society. 13: 813-9. PMID 9756151 DOI: 10.1002/mds.870130510  0.64
1998 Furukawa Y, Shimadzu M, Hornykiewicz O, Kish SJ. Molecular and biochemical aspects of hereditary progressive and dopa-responsive dystonia. Advances in Neurology. 78: 267-82. PMID 9750923  0.64
1998 Furukawa Y, Kish SJ. Influence of development and aging on brain biopterin: Implications for dopa-responsive dystonia onset Neurology. 51: 632-634. PMID 9710058  0.64
1998 Furukawa Y, Kish SJ, Bebin EM, Jacobson RD, Fryburg JS, Wilson WG, Shimadzu M, Hyland K, Trugman JM. Dystonia with motor delay in compound heterozygotes for GTP-cyclohydrolase I gene mutations. Annals of Neurology. 44: 10-6. PMID 9667588 DOI: 10.1002/ana.410440107  0.64
1998 Morrison LD, Cao XC, Kish SJ. Ornithine decarboxylase in human brain: Influence of aging, regional distribution, and Alzheimer's disease Journal of Neurochemistry. 71: 288-294. PMID 9648877  0.64
1998 Muenter MD, Forno LS, Hornykiewicz O, Kish SJ, Maraganore DM, Caselli RJ, Okazaki H, Howard FM, Snow BJ, Calne DB. Hereditary form of parkinsonism--dementia. Annals of Neurology. 43: 768-81. PMID 9629847 DOI: 10.1002/ana.410430612  0.64
1998 Furukawa Y, Lang AE, Trugman JM, Bird TD, Hunter A, Sadeh M, Tagawa T, St George-Hyslop PH, Guttman M, Morris LW, Hornykiewicz O, Shimadzu M, Kish SJ. Gender-related penetrance and de novo GTP-cyclohydrolase I gene mutations in dopa-responsive dystonia. Neurology. 50: 1015-20. PMID 9566388  0.64
1998 Ross BM, Moszczynska A, Erlich J, Kish SJ. Low activity of key phospholipid catabolic and anabolic enzymes in human substantia nigra: possible implications for Parkinson's disease. Neuroscience. 83: 791-8. PMID 9483562 DOI: 10.1016/S0306-4522(97)00454-5  0.64
1998 Ross BM, Moszczynska A, Erlich J, Kish SJ. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity. Journal of Neurochemistry. 70: 786-93. PMID 9453575  0.64
1997 Bettendorff L, Mastrogiacomo F, Wins P, Kish SJ, Grisar T, Ball MJ. Low thiamine diphosphate levels in brains of patients with frontal lobe degeneration of the non-Alzheimer's type. Journal of Neurochemistry. 69: 2005-10. PMID 9349545  0.64
1997 Kish SJ. Brain energy metabolizing enzymes in Alzheimer's disease: α-ketoglutarate dehydrogenase complex and cytochrome oxidase Annals of the New York Academy of Sciences. 826: 218-228. PMID 9329693 DOI: 10.1111/j.1749-6632.1997.tb48473.x  0.64
1997 Campuzano V, Montermini L, Lutz Y, Cova L, Hindelang C, Jiralerspong S, Trottier Y, Kish SJ, Faucheux B, Trouillas P, Authier FJ, Dürr A, Mandel JL, Vescovi A, Pandolfo M, et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Human Molecular Genetics. 6: 1771-80. PMID 9302253 DOI: 10.1093/hmg/6.11.1771  0.64
1997 Montermini L, Kish SJ, Jiralerspong S, Lamarche JB, Pandolfo M. Somatic mosaicism for Friedreich's ataxia GAA triplet repeat expansions in the central nervous system. Neurology. 49: 606-10. PMID 9270608  0.64
1997 Guttman M, Burkholder J, Kish SJ, Hussey D, Wilson A, DaSilva J, Houle S. [11C]RTI-32 PET studies of the dopamine transporter in early dopa- naive Parkinson's disease: Implications for the symptomatic threshold Neurology. 48: 1578-1583. PMID 9191769  0.64
1997 Ross BM, Hudson C, Erlich J, Warsh JJ, Kish SJ. Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2. Archives of General Psychiatry. 54: 487-94. PMID 9152103  0.64
1997 Tatton NA, Kish SJ. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining Neuroscience. 77: 1037-1048. PMID 9130785  0.64
1997 Ross BM, Moszczynska A, Blusztajn JK, Sherwin A, Lozano A, Kish SJ. Phospholipid biosynthetic enzymes in human brain. Lipids. 32: 351-8. PMID 9113621 DOI: 10.1007/s11745-997-0044-x  0.64
1997 Kish SJ, Guttman M, Robitaille Y, el-Awar M, Chang LJ, Levey AI. Striatal dopamine nerve terminal markers but not nigral cellularity are reduced in spinocerebellar ataxia type 1. Neurology. 48: 1109-11. PMID 9109912  0.64
1997 Mathews R, Li PP, Young LT, Kish SJ, Warsh JJ. Increased Gα(q/11) immunoreactivity in postmortem occipital cortex from patients with bipolar affective disorder Biological Psychiatry. 41: 649-656. PMID 9066988 DOI: 10.1016/S0006-3223(96)00113-8  0.64
1997 Rahman S, Li PP, Young LT, Kofman O, Kish SJ, Warsh JJ. Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder. Journal of Neurochemistry. 68: 297-304. PMID 8978738  0.64
1996 Przedborski S, Donaldson D, Jakowec M, Kish SJ, Guttman M, Rosoklija G, Hays AP. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis. Annals of Neurology. 39: 158-65. PMID 8967746 DOI: 10.1002/ana.410390204  0.64
1996 Ross BM, Moszczynska A, Kalasinsky K, Kish SJ. Phospholipase A2 activity is selectively decreased in the striatum of chronic cocaine users. Journal of Neurochemistry. 67: 2620-3. PMID 8931499  0.64
1996 Young LT, Asghari V, Li PP, Kish SJ, Fahnestock M, Warsh JJ. Stimulatory G-protein alpha-subunit mRNA levels are not increased in autopsied cerebral cortex from patients with bipolar disorder. Brain Research. Molecular Brain Research. 42: 45-50. PMID 8915579 DOI: 10.1016/S0169-328X(96)00112-X  0.64
1996 Bettendorff L, Mastrogiacomo F, LaMarche J, Dožić S, Kish SJ. Brain levels of thiamine and its phosphate esters in Friedreich's ataxia and spinocerebellar ataxia type 1 Movement Disorders. 11: 437-439. PMID 8813226 DOI: 10.1002/mds.870110415  0.64
1996 Wilson JM, Levey AI, Bergeron C, Kalasinsky K, Ang L, Peretti F, Adams VI, Smialek J, Anderson WR, Shannak K, Deck J, Niznik HB, Kish SJ. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Annals of Neurology. 40: 428-39. PMID 8797532 DOI: 10.1002/ana.410400312  0.64
1996 Wilson JM, Levey AI, Rajput A, Ang L, Guttman M, Shannak K, Niznik HB, Hornykiewicz O, Pifl C, Kish SJ. Differential changes in neurochemical markers of striatal dopamine nerve terminals in idiopathic Parkinson's disease. Neurology. 47: 718-26. PMID 8797470  0.64
1996 Morrison LD, Smith DD, Kish SJ. Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease. Journal of Neurochemistry. 67: 1328-31. PMID 8752143  0.64
1996 Mastrogiacomo F, LaMarche J, Dozić S, Lindsay G, Bettendorff L, Robitaille Y, Schut L, Kish SJ. Immunoreactive levels of alpha-ketoglutarate dehydrogenase subunits in Friedreich's ataxia and spinocerebellar ataxia type 1. Neurodegeneration : a Journal For Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration. 5: 27-33. PMID 8731379 DOI: 10.1006/neur.1996.0004  0.64
1996 Ma TK, Ang LC, Mamelak M, Kish SJ, Young B, Lewis AJ. Narcolepsy secondary to fourth ventricular subependymoma. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 23: 59-62. PMID 8673965  0.64
1996 Wilson JM, Kalasinsky KS, Levey AI, Bergeron C, Reiber G, Anthony RM, Schmunk GA, Shannak K, Haycock JW, Kish SJ. Striatal dopamine nerve terminal markers in human, chronic methamphetamine users. Nature Medicine. 2: 699-703. PMID 8640565 DOI: 10.1038/nm0696-699  0.64
1996 Jope RS, Song L, Li PP, Young LT, Kish SJ, Pacheco MA, Warsh JJ. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain Journal of Neurochemistry. 66: 2402-2409. PMID 8632163  0.64
1996 Wilson JM, Kish SJ. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat Journal of Neuroscience. 16: 3507-3510. PMID 8627383  0.64
1996 Furukawa Y, Shimadzu M, Rajput AH, Shimizu Y, Tagawa T, Mori H, Yokochi M, Narabayashi H, Hornykiewicz O, Mizuno Y, Kish SJ. GTP-cyclohydrolase I gene mutations in hereditary progressive amd dopa-responsive dystonia. Annals of Neurology. 39: 609-17. PMID 8619546 DOI: 10.1002/ana.410390510  0.64
1996 Mastrogiacomo F, Lindsay JG, Bettendorff L, Rice J, Kish SJ. Brain protein and α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease Annals of Neurology. 39: 592-598. PMID 8619544 DOI: 10.1002/ana.410390508  0.64
1996 Mastrogiacomo F, Bettendorff L, Grisar T, Kish SJ. Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer's disease Annals of Neurology. 39: 585-591. PMID 8619543 DOI: 10.1002/ana.410390507  0.64
1996 Bettendorff L, Mastrogiacomo F, Kish SJ, Grisar T. Thiamine, thiamine phosphates, and their metabolizing enzymes in human brain Journal of Neurochemistry. 66: 250-258. PMID 8522961  0.64
1995 Robitaille Y, Schut L, Kish SJ. Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype. Acta Neuropathologica. 90: 572-81. PMID 8615077 DOI: 10.1007/BF00318569  0.64
1995 Ross BM, Sherwin AL, Kish SJ. Multiple forms of the enzyme glycerophosphodiesterase are present in human brain. Lipids. 30: 1075-81. PMID 8614297 DOI: 10.1007/BF02536607  0.64
1995 Morrison LD, Kish SJ. Brain polyamine levels are altered in Alzheimer's disease Neuroscience Letters. 197: 5-8. PMID 8545054 DOI: 10.1016/0304-3940(95)11881-V  0.64
1995 Zhong XH, Haycock JW, Shannak K, Robitaille Y, Fratkin J, Koeppen AH, Hornykiewicz O, Kish SJ. Striatal dihydroxyphenylalanine decarboxylase and tyrosine hydroxylase protein in idiopathic Parkinson's disease and dominantly inherited olivopontocerebellar atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 10-7. PMID 7885342 DOI: 10.1002/mds.870100104  0.64
1995 Ross BM, Kim DK, Bonventre JV, Kish SJ. Characterization of a novel phospholipase A2 activity in human brain. Journal of Neurochemistry. 64: 2213-21. PMID 7722506  0.64
1995 Ch. Wolters E, Tissingh G, Bergmans PLM, Kuiper MA, Agid Y, Cervera P, Hirsch E, Hornykiewicz O, Kish SJ, Alexander GE, Crutcher MD, Bergman H, Wichmann T, Delong MR, Strick PL, et al. Dopamine agonists in parkinson's disease Neurology. 45: S28-S34. PMID 7715794  0.64
1995 Kish SJ, Zhong XH, Hornykiewicz O, Haycock JW. Striatal 3,4-dihydroxyphenylalanine decarboxylase in aging: disparity between postmortem and positron emission tomography studies? Annals of Neurology. 38: 260-4. PMID 7654075 DOI: 10.1002/ana.410380220  0.64
1995 Morrison LD, Becker L, Ang LC, Kish SJ. Polyamines in human brain: regional distribution and influence of aging. Journal of Neurochemistry. 65: 636-42. PMID 7616219  0.64
1994 Pristupa ZB, Wilson JM, Hoffman BJ, Kish SJ, Niznik HB. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. Molecular Pharmacology. 45: 125-35. PMID 8302271  0.64
1994 Morrison LD, Sherwin AL, Carmant L, Kish SJ. Activity of S-adenosylmethionine decarboxylase, a key regulatory enzyme in polyamine biosynthesis, is increased in epileptogenic human cortex. Archives of Neurology. 51: 581-4. PMID 8198469 DOI: 10.1001/archneur.1994.00540180059014  0.64
1994 Wilson JM, Nobrega JN, Carroll ME, Niznik HB, Shannak K, Lac ST, Pristupa ZB, Dixon LM, Kish SJ. Heterogeneous subregional binding patterns of 3H-WIN 35,428 and 3H-GBR 12,935 are differentially regulated by chronic cocaine self-administration. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 14: 2966-79. PMID 8182452  0.64
1994 Joffe RT, Nobrega JN, Kish SJ, Calvo R, Dixon LM, Wilson JM, Morreale de Escobar G. Regional thyroid hormone levels in rat brain Psychoneuroendocrinology. 19: 773-777. PMID 7991764 DOI: 10.1016/0306-4530(94)90024-8  0.64
1994 Kish SJ, el-Awar M, Stuss D, Nobrega J, Currier R, Aita JF, Schut L, Zoghbi HY, Freedman M. Neuropsychological test performance in patients with dominantly inherited spinocerebellar ataxia: relationship to ataxia severity. Neurology. 44: 1738-46. PMID 7936307  0.64
1994 Ross BM, Kish SJ. Characterization of lysophospholipid metabolizing enzymes in human brain. Journal of Neurochemistry. 63: 1839-48. PMID 7931340  0.64
1994 Kish SJ, Chang LJ, Dixon LM, Robitaille Y, DiStefano L. Cerebellar glutamate metabolizing enzymes in spinocerebellar ataxia type I. Metabolic Brain Disease. 9: 97-103. PMID 7914669 DOI: 10.1007/BF01996077  0.64
1994 Young LT, Li PP, Kish SJ, Warsh JJ. Cerebral cortex β-adrenoceptor binding in bipolar affective disorder Journal of Affective Disorders. 30: 89-92. PMID 7911133 DOI: 10.1016/0165-0327(94)90035-3  0.64
1994 Mastrogiacomo F, Kish SJ. Cerebellar α-ketoglutarate dehydrogenase activity is reduced in spinocerebellar ataxia type 1 Annals of Neurology. 35: 624-626. PMID 7910005 DOI: 10.1002/ana.410350519  0.64
1994 Wilson JM, Carroll ME, Lac ST, DiStefano LM, Kish SJ. Choline acetyltransferase activity is reduced in rat nucleus accumbens after unlimited access to self-administration of cocaine Neuroscience Letters. 180: 29-32. PMID 7877755 DOI: 10.1016/0304-3940(94)90906-7  0.64
1994 Wilson JM, Nobrega J, Corrigall WA, Coen KM, Shannak K, Kish SJ. Amygdala dopamine levels are markedly elevated after self- but not passive-administration of cocaine Brain Research. 668: 39-45. PMID 7704616 DOI: 10.1016/0006-8993(94)90508-8  0.64
1994 Young LT, Warsh JJ, Kish SJ, Shannak K, Hornykeiwicz O. Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder Biological Psychiatry. 35: 121-127. PMID 7513191 DOI: 10.1016/0006-3223(94)91201-7  0.64
1993 Kish SJ, Young T, Li PP, Siu KP, Robitaille Y, Ball MJ, Schut L, Warsh JJ. Elevated stimulatory and reduced inhibitory G protein alpha subunits in cerebellar cortex of patients with dominantly inherited olivopontocerebellar atrophy. Journal of Neurochemistry. 60: 1816-20. PMID 8473899  0.64
1993 Young LT, Li PP, Kish SJ, Siu KP, Kamble A, Hornykiewicz O, Warsh JJ. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. Journal of Neurochemistry. 61: 890-8. PMID 8395565  0.64
1993 Trevor Young L, Li PP, Siu KP, Kish SJ, Warsh JJ. Regional distribution of guanine nucleotide binding proteins (Gs and Gi α) in human brain: correlation with adenylyl cyclase activity Neurochemistry International. 22: 285-291. PMID 8382985 DOI: 10.1016/0197-0186(93)90057-C  0.64
1993 Morrison LD, Bergeron C, Kish SJ. Brain S-adenosylmethionine decarboxylase activity is increased in Alzheimer's disease Neuroscience Letters. 154: 141-144. PMID 8361629 DOI: 10.1016/0304-3940(93)90191-M  0.64
1993 Morrison LD, Becker L, Kish SJ. S-adenosylmethionine decarboxylase in human brain. Regional distribution and influence of aging Developmental Brain Research. 73: 237-241. PMID 8353934 DOI: 10.1016/0165-3806(93)90143-X  0.64
1993 Nitsch RM, Blusztajn JK, Doyle FM, Robitaille Y, Wurtman RJ, Growdon JH, Kish SJ. Phospholipid metabolite levels are altered in cerebral cortex of patients with dominantly inherited olivopontocerebellar atrophy. Neuroscience Letters. 161: 191-4. PMID 8272265 DOI: 10.1016/0304-3940(93)90291-R  0.64
1993 Mastrogiacomo F, Bergeron C, Kish SJ. Brain α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease Journal of Neurochemistry. 61: 2007-2014. PMID 8245957 DOI: 10.1111/j.1471-4159.1993.tb07436.x  0.64
1993 Kish SJ, Robitaille Y, el-Awar M, Schut L, DiStefano L, Ball MJ, Mazurek MF. Reduced cerebral cortical but elevated striatal concentration of somatostatin-like immunoreactivity in dominantly inherited olivopontocerebellar atrophy. Journal of Neurology, Neurosurgery, and Psychiatry. 56: 1013-5. PMID 8105030 DOI: 10.1136/jnnp.56.9.1013  0.64
1992 Kish SJ, Shannak K, Rajput A, Deck JH, Hornykiewicz O. Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease. Journal of Neurochemistry. 58: 642-8. PMID 1729408 DOI: 10.1111/j.1471-4159.1992.tb09766.x  0.64
1992 Wilson JM, Nobrega JN, Corrigall W, Shannak K, Deck JHN, Kish SJ. Influence of chronic cocaine on monoamine neurotransmitters in human brain and animal model: Preliminary observations Annals of the New York Academy of Sciences. 654: 461-463. PMID 1632604  0.64
1992 Kish SJ, Mamelak M, Slimovitch C, Dixon LM, Lewis A, Shannak K, DiStefano L, Chang LJ, Hornykiewicz O. Brain neurotransmitter changes in human narcolepsy. Neurology. 42: 229-34. PMID 1370862  0.64
1992 Kish SJ, Robitaille Y, el-Awar M, Clark B, Schut L, Ball MJ, Young LT, Currier R, Shannak K. Striatal monoamine neurotransmitters and metabolites in dominantly inherited olivopontocerebellar atrophy. Neurology. 42: 1573-7. PMID 1353622  0.64
1992 Kish SJ, Bergeron C, Rajput A, Dozic S, Mastrogiacomo F, Chang LJ, Wilson JM, DiStefano LM, Nobrega JN. Brain cytochrome oxidase in Alzheimer's disease. Journal of Neurochemistry. 59: 776-9. PMID 1321237  0.64
1992 Petrasek JS, Nobrega JN, Kish SJ, Burnham WM. Autoradiographic analysis of [35S]TBPS binding in entorhinal cortex-kindled rat brains. Brain Research. 570: 167-72. PMID 1319792 DOI: 10.1016/0006-8993(92)90578-W  0.64
1992 Kish SJ, Robitaille Y, Schut L, el-Awar M, Ball MJ, Shannak K. Normal serotonin but elevated 5-hydroxyindoleacetic acid concentration in cerebellar cortex of patients with dominantly-inherited olivopontocerebellar atrophy. Neuroscience Letters. 144: 84-6. PMID 1279488 DOI: 10.1016/0304-3940(92)90721-I  0.64
1991 Young LT, Li PP, Kish SJ, Siu KP, Warsh JJ. Postmortem cerebral cortex Gs α-subunit levels are elevated in bipolar affective disorder Brain Research. 553: 323-326. PMID 1933291 DOI: 10.1016/0006-8993(91)90843-K  0.64
1991 Warsh JJ, Politsky JM, Li PP, Kish SJ, Hornykiewicz O. Reduced striatal [3H]inositol 1,4,5-trisphosphate binding in Huntington's disease. Journal of Neurochemistry. 56: 1417-22. PMID 1825844  0.64
1991 Kish SJ, Du F, Parks DA, Robitaille Y, Ball MJ, Schut L, Hornykiewicz O, Schwarcz R. Quinolinic acid catabolism is increased in cerebellum of patients with dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 29: 100-4. PMID 1825460 DOI: 10.1002/ana.410290119  0.64
1991 Kish SJ, Wilson JM, Fletcher PJ. The polyamine synthesis inhibitor α-difluoromethylornithine is neuroprotective against N-methyl-D-aspartate-induced brain damage in vivo European Journal of Pharmacology. 209: 101-103. PMID 1814755 DOI: 10.1016/0014-2999(91)90017-K  0.64
1991 Young LT, Warsh JJ, Li PP, Siu KP, Becker L, Gilbert J, Hornykiewicz O, Kish SJ. Maturational and aging effects on guanine nucleotide binding protein immunoreactivity in human brain. Brain Research. Developmental Brain Research. 61: 243-8. PMID 1752042 DOI: 10.1016/0165-3806(91)90137-8  0.64
1991 Kish SJ, Robitaille Y, el-Awar M, Gilbert J, Deck J, Chang LJ, Schut L. Brain amino acid reductions in one family with chromosome 6p-linked dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 30: 780-4. PMID 1686387 DOI: 10.1002/ana.410300606  0.64
1990 Kish SJ, Robitaille Y, Ball M, Gilbert J, Deck JH, Chang LJ, Schut L. Glycerophosphoethanolamine concentration is elevated in brain of patients with dominantly inherited olivopontocerebellar atrophy. Neuroscience Letters. 120: 209-11. PMID 2293106 DOI: 10.1016/0304-3940(90)90040-G  0.64
1990 Nobrega JN, Kish SJ, Burnham WM. Regional brain [3H]muscimol binding in kindled rat brain: a quantitative autoradiographic examination. Epilepsy Research. 6: 102-9. PMID 2167222 DOI: 10.1016/0920-1211(90)90084-9  0.64
1990 Kish SJ, Distefano LM, Dozic S, Robitaille Y, Rajput A, Deck JH, Hornykiewicz O. [3H]vesamicol binding in human brain cholinergic deficiency disorders. Neuroscience Letters. 117: 347-52. PMID 2151294 DOI: 10.1016/0304-3940(90)90689-7  0.64
1990 Kish SJ, Kleinert R, Minauf M, Gilbert J, Walter GF, Slimovitch C, Maurer E, Rezvani Y, Myers R, Hornykiewicz O. Brain neurotransmitter changes in three patients who had a fatal hyperthermia syndrome. The American Journal of Psychiatry. 147: 1358-63. PMID 2133042  0.64
1989 Kish SJ, Robitaille Y, el-Awar M, Deck JH, Simmons J, Schut L, Chang LJ, DiStefano L, Freedman M. Non-Alzheimer-type pattern of brain cholineacetyltransferase reduction in dominantly inherited olivopontocerebellar atrophy. Annals of Neurology. 26: 362-7. PMID 2802535 DOI: 10.1002/ana.410260309  0.64
1989 Nobrega JN, Kish SJ, Burnham WM. Autoradiographic analysis of benzodiazepine binding in entorhinal-kindled rat brains. Brain Research. 498: 315-22. PMID 2790486 DOI: 10.1016/0006-8993(89)91110-4  0.64
1989 Kish SJ, Li PP, Robitaille Y, Currier R, Gilbert J, Schut L, Warsh JJ. Cerebellar [3H]inositol 1,4,5-trisphosphate binding is markedly decreased in human olivopontocerebellar atrophy. Brain Research. 489: 373-6. PMID 2787192 DOI: 10.1016/0006-8993(89)90874-3  0.64
1988 Kish SJ, Shannak K, Hornykiewicz O. Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. The New England Journal of Medicine. 318: 876-80. PMID 3352672 DOI: 10.1056/NEJM198804073181402  0.64
1988 Young LT, Li PP, Kish SJ, Chiu AS, Warsh JJ. [3H]Inositol 1,4,5-trisphosphate binding in human cerebral cortex Neuroscience Letters. 87: 283-287. PMID 3260018 DOI: 10.1016/0304-3940(88)90462-4  0.64
1988 Kish SJ, Olivier A, Dubeau F, Robitaille Y, Sherwin AL. Increased activity of choline acetyltransferase and acetylcholinesterase in actively epileptic human cerebral cortex. Epilepsy Research. 2: 227-31. PMID 3197693 DOI: 10.1016/0920-1211(88)90012-5  0.64
1988 Kish SJ, Schut L, Simmons J, Gilbert J, Chang LJ, Rebbetoy M. Brain acetylcholinesterase activity is markedly reduced in dominantly-inherited olivopontocerebellar atrophy. Journal of Neurology, Neurosurgery, and Psychiatry. 51: 544-8. PMID 3164041  0.64
1988 Gilbert JJ, Kish SJ, Chang LJ, Morito C, Shannak K, Hornykiewicz O. Dementia, parkinsonism, and motor neuron disease: neurochemical and neuropathological correlates. Annals of Neurology. 24: 688-91. PMID 2904794 DOI: 10.1002/ana.410240518  0.64
1988 Kish SJ, Dixon LM, Sherwin AL. Aspartic acid aminotransferase activity is increased in actively spiking compared with non-spiking human epileptic cortex Journal of Neurology Neurosurgery and Psychiatry. 51: 552-556. PMID 2898010  0.64
1988 Young LT, Kish SJ, Li PP, Warsh JJ. Decreased brain [3H]inositol 1,4,5-trisphosphate binding in Alzheimer's disease Neuroscience Letters. 94: 198-202. PMID 2853852 DOI: 10.1016/0304-3940(88)90295-9  0.64
1988 Hornykiewicz O, Kish SJ, Becker LE, Farley I, Shannak K. Biochemical evidence for brain neurotransmitter changes in idiopathic torsion dystonia (dystonia musculorum deformans). Advances in Neurology. 50: 157-65. PMID 2456673  0.64
Show low-probability matches.